Articles by Joseph Mikhael, MD
Among the major dilemmas persisting in CAR-T therapy use is how to balance malignancy risks.
Live from Chicago, the panel discussed unanswered questions in CAR-T.
Dr. Mikhael reflected on how the BOSTON and STOMP studies impacted the myeloma treatment paradigm.
Researchers conducted interviews to gather the perspectives of both clinicians and nurses.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.